Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Clinical and Translational Science|December 17, 2024
Endogenous plasma riboflavin is not a viable BCRP biomarker in humanJohn P Savaryn, Ryota Kikuchi, Yuli Qian, et al.
Clinical Pharmacology in Drug Development|February 27, 2024
Pharmacokinetics, Safety, and Tolerability of Cedirogant in Healthy Japanese and Chinese AdultsMohamed-Eslam F Mohamed, Yuli Qian, Ronilda D'Cunha, et al.
Clinical Pharmacology in Drug Development|April 20, 2026
Effects of Cedirogant on the Pharmacokinetics of Sensitive Cytochrome P450 Probe SubstratesRonilda D'Cunha, Yuli Qian, Shuai Hao, et al.
Clinical Pharmacokinetics|August 1, 2026
Exposure-Response Analyses to Inform the Optimal Epcoritamab Monotherapy Dosing Regimen in Relapsed or Refractory Follicular LymphomaMahipal Sinnollareddy, Kinjal Sanghavi, Leonid Gibiansky, et al.
International Journal of Rheumatic Diseases|November 15, 2021
Upadacitinib in patients from China, Brazil, and South Korea with rheumatoid arthritis and an inadequate response to conventional therapyXiaofeng Zeng, Dongbao Zhao, Sebastiao C Radominski, et al.
Clinical Pharmacology and Therapeutics|May 15, 2026
Model-Informed Dosing Strategies for Epcoritamab Monotherapy in Relapsed or Refractory Large B-Cell LymphomaXiaozhi Liao, Tommy Li, Steven Xu, et al.
Lancet (London, England)|June 18, 2018
Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trialMark C Genovese, Roy Fleischmann, Bernard Combe, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 9, 2020
Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate-Naive Patients With Moderately-to-Severely Active Rheumatoid Arthritis (SELECT-EARLY): A Multicenter, Multi-Country, Randomized, Double-Blind, Active Comparator-Controlled TrialRonald van Vollenhoven, Tsutomu Takeuchi, Aileen L Pangan, et al.
Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India|June 5, 2023
A Cervical Thymic Cyst in an Adult Female; A Case Report and Comprehensive Literature ReviewShadi Awny, Marwa Alashram, Aya Eladl, et al.
Alimentary Pharmacology & Therapeutics|September 23, 2024
Individualized HCC surveillance using risk stratification scores in advanced fibrosis and cirrhotic HCV patients who achieved SVR: Prospective studyGamal Shiha, Ayman Hassan, Nasser Mousa, et al.
Pageof 8